Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety The Omicron-specific Pfizer vaccine is about to start its clinical trials. The drugmaker aims to enroll more than 1,400 participants. by Griffin Davis
'Spray and Pray' iMessage Scam Haunts iPhone Owners: How to Avoid Losing Your Hard-Earned Money From it
Building on C919's Success, China's Comac Unveils Plans for C939 Widebody Jet to Rival Boeing and Airbus